Does TRIHEPTANOIN Cause Hospitalisation? 22 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 22 reports of Hospitalisation have been filed in association with TRIHEPTANOIN (DOJOLVI). This represents 4.4% of all adverse event reports for TRIHEPTANOIN.
22
Reports of Hospitalisation with TRIHEPTANOIN
4.4%
of all TRIHEPTANOIN reports
1
Deaths
22
Hospitalizations
How Dangerous Is Hospitalisation From TRIHEPTANOIN?
Of the 22 reports, 1 (4.5%) resulted in death, 22 (100.0%) required hospitalization, and 1 (4.5%) were considered life-threatening.
Is Hospitalisation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TRIHEPTANOIN. However, 22 reports have been filed with the FAERS database.
What Other Side Effects Does TRIHEPTANOIN Cause?
Vomiting (79)
Diarrhoea (70)
Rhabdomyolysis (53)
Off label use (48)
Abdominal pain upper (38)
Abdominal discomfort (34)
Blood creatine phosphokinase increased (34)
Death (29)
Nausea (26)
Gastrointestinal disorder (23)
What Other Drugs Cause Hospitalisation?
CLOZAPINE (12,144)
CINACALCET (6,997)
DARBEPOETIN ALFA (5,682)
MACITENTAN (3,414)
APIXABAN (3,315)
ADALIMUMAB (3,033)
DUPILUMAB (2,529)
LENALIDOMIDE (2,241)
DENOSUMAB (2,076)
PALIPERIDONE (2,066)
Which TRIHEPTANOIN Alternatives Have Lower Hospitalisation Risk?
TRIHEPTANOIN vs TRIHEXYPHENIDYL
TRIHEPTANOIN vs TRILACICLIB
TRIHEPTANOIN vs TRILEPTAL
TRIHEPTANOIN vs TRIMEBUTINE
TRIHEPTANOIN vs TRIMEPRAZINE